Are the current IHS guidelines for migraine drug trials being followed?

Author： Hougaard Anders Tfelt-Hansen Peer

ISSN： 1129-2369

Source： The Journal of Headache and Pain, Vol.11, Iss.6, 2010-12, pp. : 457-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Migraine and stroke: current perspectives

By Elliott Debra

Neurological Research, Vol. 30, Iss. 8, 2008-10 ,pp. : 801-812

Maney Publishing

Access to resources Recommend Favorite

New Guidelines and Questionnaires to Help Patients Manage their Migraine

By Turner Ann Lipscombe Susan Laughey William F. Rees Trevor Few Anita Dowson Andrew J.

Headache Care, Vol. 2, Iss. 3, 2005-08 ,pp. : 151-162

Informa Healthcare

Access to resources Recommend Favorite

Migraine treatment in developmental age: guidelines update

By Papetti Laura Spalice Alberto Nicita Francesco Paolino Maria Castaldo Rosa Iannetti Paola Villa Maria Parisi Pasquale

The Journal of Headache and Pain, Vol. 11, Iss. 3, 2010-06 ,pp. : 267-276

Springer Publishing Company

Access to resources Recommend Favorite

Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Russell Michael

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 135-136

Springer Publishing Company

Access to resources Recommend Favorite

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Aurora Sheena Diener Hans-Christoph Dodick David

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 137-138

Springer Publishing Company

Access to resources Recommend Favorite